Universe Pharmaceuticals (UPC) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Universe Pharmaceuticals (UPC) is Moderate Underperform.

The composite score behind that read is -0.42, weighing +0.08 of bullish evidence against -0.46 bearish.

Universe Pharmaceuticals last closed at $4.34, -3.56% on the session.

Against the IVW growth benchmark the position is -4.48% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

16 graded predictions for UPC so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Universe Pharmaceuticals is classified under Health Care / Pharmaceuticals, with a market capitalisation of $22.61M.

StockMap tracks Universe Pharmaceuticals as the 104th largest of the 128 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Moderate Underperform, 53 Neutral, 15 Strong Underperform and 6 Moderate Outperform.

On that composite Universe Pharmaceuticals ranks 99th of 128 in the group, against a group median of -0.24.